Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XBiotech Inc. Director's Dealing 2020

Feb 14, 2020

34229_dirs_2020-02-14_0e5d6486-a8e1-4685-ba08-0b8cceaf4192.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2020-02-12

Reporting Person: GUT THOMAS (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-12 Common Stock D 1868870 $30.00 Disposed 3995170 Direct

Footnotes

F1: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. The number of shares reported is an estimate, and will be amended when a final determination is made.